These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 32764874

  • 1. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
    Huang S, Zhang Z, Li W, Kong F, Yi P, Huang J, Mao D, Peng W, Zhang S.
    Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
    [Abstract] [Full Text] [Related]

  • 2. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer.
    Zhang Z, Li B, Huang J, Huang S, He D, Peng W, Zhang S.
    Med Sci Monit; 2020 Aug 31; 26():e923327. PubMed ID: 32866138
    [Abstract] [Full Text] [Related]

  • 3. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
    Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W.
    Drug Des Devel Ther; 2021 Aug 31; 15():3255-3276. PubMed ID: 34349502
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S, Sun X, Zhou Z, Tang H, Xiao R, Lv Q, Wang B, Qu J, Yu J, Sun F, Deng Z, Tian Y, Li C, Yang Z, Yang P, Rao B.
    Front Immunol; 2023 Aug 31; 14():1235575. PubMed ID: 37799727
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome via network pharmacology and molecular docking analysis.
    Zheng R, Shi S, Zhang Q, Yuan S, Guo T, Guo J, Jiang P.
    Front Cell Infect Microbiol; 2023 Aug 31; 13():1140945. PubMed ID: 37009506
    [Abstract] [Full Text] [Related]

  • 11. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
    Zhao Y, Cao Y, Yang X, Guo M, Wang C, Zhang Z, Zhang Q, Huang X, Sun M, Xi C, Tangthianchaichana J, Bai J, Du S, Lu Y.
    J Ethnopharmacol; 2022 Nov 15; 298():115629. PubMed ID: 35988839
    [Abstract] [Full Text] [Related]

  • 12. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidii Fructus in Treating Colorectal Cancer.
    Wei Z, Zhang X, Peng A, Liu C, Pang J, Zhang Y, Duan X.
    Comb Chem High Throughput Screen; 2024 Nov 15; 27(18):2667-2680. PubMed ID: 37861043
    [Abstract] [Full Text] [Related]

  • 13. Exploring the mechanism of Erteng-Sanjie capsule in treating gastric and colorectal cancers via network pharmacology and in-vivo validation.
    Zhang W, Wang Y, Yu H, Jin Z, Yuan Y, Liu L, Zhou J.
    J Ethnopharmacol; 2024 Jun 12; 327():117945. PubMed ID: 38428659
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.
    Yuan X, Huang H, Yu C, Tang Z, Li Y.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep 12; 397(9):6507-6521. PubMed ID: 38446216
    [Abstract] [Full Text] [Related]

  • 16. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S, Zhang P, Yan Y, Xu W, Li J, Wang L, Wang N, Huang Y.
    J Ethnopharmacol; 2023 Aug 10; 312():116507. PubMed ID: 37080367
    [Abstract] [Full Text] [Related]

  • 17. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z, Liu J, Liu Y, Shi D, He Y, Zhao P.
    J Ethnopharmacol; 2021 Apr 06; 269():113696. PubMed ID: 33358854
    [Abstract] [Full Text] [Related]

  • 18. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T, Wang Q, Han S, Lu Y, Xu Y, Wang Y.
    Biomed Res Int; 2022 Apr 06; 2022():9214589. PubMed ID: 35837376
    [Abstract] [Full Text] [Related]

  • 19. Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.
    Sun T, Quan W, Peng S, Yang D, Liu J, He C, Chen Y, Hu B, Tuo Q.
    Drug Des Devel Ther; 2022 Apr 06; 16():1621-1645. PubMed ID: 35669282
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification.
    Lin X, Chi W, Geng X, Jiang Q, Ma B, Dai B, Sui Y, Jiang J.
    Comb Chem High Throughput Screen; 2024 Apr 06; 27(17):2583-2597. PubMed ID: 38178684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.